Found 4 matching trials
Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients PHASE4 The purpose of this study is to compare the safety and efficacy of differen...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients PHASE2 This study was to compare CFZ533 to tacrolimus (TAC) in prevention of organ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR PHASE4 The purpose of this study is to determine if the combination of once-daily ...
Show More Location
University of Southern California
Learn More & Join Trial
Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen PHASE2 The primary objective is to evaluate a NULOJIX® (belatacept) based regimens...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial